Skip to main content
Premium Trial:

Request an Annual Quote

J&J Pharma R&D Extends Lexicon Access Agreement

NEW YORK, Jan. 8-Johnson & Johnson Pharmaceutical Research & Development has extended its access agreement for Lexicon Genetics' libraries of knockout mice and mouse stem cell clones through the end of 2003, Lexicon said today.

 

The agreement continues a deal made in 2000 in which the pharmaceutical company's research wing obtained access to Lexicon's OmniBank clone library and its set of knockout mice.

 

Financial specifics of the agreement were not disclosed. For further information, see the press release.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.